NCT05992818 - Clinical Trial References

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Citation(s)

American Psychiatric Association
Diagnostic and statistical manual of mental disorders (DSM-5?). 5th ed. Arlington, American Psychiatric Association Publishing. 2013, pp 596-601.
Cinar MA,Ozmenler KN ,Ozsahin A ,Trzepacz Paula T
Dusunen Adam The Journal of Psychiatry and Neurological Sciences 2014; 3(27): 186-193 DOI: 10.5350/DAJPN2014270301
Janssen TL, Alberts AR, Hooft L, Mattace-Raso F, Mosk CA, van der Laan L
Prevention of postoperative delirium in elderly patients planned for elective surgery: systematic review and meta-analysis. Clin Interv Aging. 2019 Jun 19;14:1095-1117. doi: 10.2147
Oh ST, Park JY
Postoperative delirium. Korean J Anesthesiol. 2019 Feb;72(1):4-12. doi: 10.4097/kja.d.18.00073.1. Epub 2018 Aug 24.
Palihnich K, Inouye SK, Marcantonio ER
The 3D CAM Training Manual for Research. 2014; Boston: Hospital Elder Life Program

Comparison of DRS-R-98 (The Delirium Rating Scale--Revised-98) and 3D-CAM (3-minute Diagnostic Assessment for CAM-Confusion Assessment Method-defined Delirium) in the Assessment of Postoperative Delirium in Elderly Patients

Details for clinical trial NCT05992818

Clinical trial NCT05992818 - References